CLINICAL_TRIALS
trial_result
· 2023-12-15
Clinical Trial Update: Cilostazol for HFpEF [Phase 2]
Summary
Phase 2 trial update for cilostazol in heart failure with preserved ejection fraction has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: COMPLETED | Results posted: 2023-12-15